Evidence map›Paper›PMID 30262740›Full record

ArticleInternational journal of environmental research and public health2018

The Economic Impact of Herpes Zoster Vaccine Disparities in Elderly United States Blacks.

La'Marcus T Wingate, Keisha Stubbs, Iman Ahmed, Rachel K Mayaka, Mary K Maneno, Earl Ettienne, Oluchi Elekwachi, Veronica Clarke-Tasker

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of environmental research and public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

La'Marcus T WingateCenter for Minority Health Services Research, 2300 4th Street NW, Annex 3, Washington, DC 20059, USA. lamarcus.wingate@howard.edu.
Keisha StubbsHoward University College of Pharmacy, Howard University, 2300 4th Street NW, Chauncey Cooper Hall, Washington, DC 20059, USA. keisha.stubbs@bison.howard.edu.
Iman AhmedHoward University College of Pharmacy, Howard University, 2300 4th Street NW, Chauncey Cooper Hall, Washington, DC 20059, USA. iman.ahmed@bison.howard.edu.
Rachel K MayakaCenter for Minority Health Services Research, 2300 4th Street NW, Annex 3, Washington, DC 20059, USA. rachel.mayaka@bison.howard.edu.
Mary K ManenoCenter for Minority Health Services Research, 2300 4th Street NW, Annex 3, Washington, DC 20059, USA. mary.maneno@howard.edu.
Earl EttienneCenter for Minority Health Services Research, 2300 4th Street NW, Annex 3, Washington, DC 20059, USA. earl.ettienne@howard.edu.
Oluchi ElekwachiUS Food and Drug Administration, Office of Minority Health, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA. Oluchi.elekwachi@fda.hhs.gov.
Veronica Clarke-TaskerHoward University College of Nursing and Allied Health Sciences, Howard University, 516 Bryant Street NW, Washington, DC 20059, USA. vclarke-tasker@howard.edu.
Howard University · USOffice of Minority Health · USUnited States Food and Drug Administration · US

Funding

PROTEOMICS CORE FACILITYG12MD007597 · NIMHD · HOWARD UNIVERSITY · PI SOUTHERLAND, WILLIAM M. · 2012 to 2018
$14.8M
NIMHD NIH HHS G12MD007597
6 · The paper itself

Abstract

There are persistent disparities with regard to receipt of herpes zoster vaccine among elderly blacks, but no data is available regarding the public health or economic impact of these disparities. A decision tree was constructed with multiple Markov nodes in order to estimate the preventable cases of herpes zoster occurring among elderly blacks due to disparities in receipt of herpes zoster vaccine and to quantify the economic costs associated with these disparities. The model was constructed to examine the number of herpes zoster cases occurring among elderly blacks from the age of 60 to 84 over a 20 year period and also calculated costs due to herpes zoster complications and lost productivity. Achievement of health equity would prevent over 34,500 cases of herpes zoster from occurring in the future and avert over $180 million in lost productivity and treatment costs as a result of these cases of herpes zoster. These results help to show that thousands of cases of herpes zoster could be prevented if blacks were vaccinated at the same frequency as whites and help to show the benefit of implementing viable strategies to achieving this goal.

Indexed as

Cost-Benefit AnalysisHealth Status DisparitiesAgedAged, 80 and overBlack or African AmericanBlack PeopleFemaleHealth EquityHerpes ZosterHerpes Zoster VaccineHumansMaleMiddle AgedPublic HealthUnited StatesVaccinationHerpes Zoster Vaccineblackselderlyherpes zosterseniorsshinglesvaccination

Identifiers

PMID30262740
PMCPMC6210735
OpenAlexW2893077277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.